Page last updated: 2024-09-03

y 27632 and ccg 1423

y 27632 has been researched along with ccg 1423 in 2 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(ccg 1423)
Trials
(ccg 1423)
Recent Studies (post-2010) (ccg 1423)
1,924389129024

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YH; Longo, FM; Lu, Q; Massa, SM; Zhou, H1
Dulin, N; Kach, J; Kregel, S; Ngam, C; Sandbo, N; Torr, E1

Other Studies

2 other study(ies) available for y 27632 and ccg 1423

ArticleYear
Signaling through Rho GTPase pathway as viable drug target.
    Current medicinal chemistry, 2009, Volume: 16, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Aminoquinolines; Anilides; Animals; Benzamides; Cardiovascular Diseases; Humans; Lung Diseases; Neoplasms; Nervous System Diseases; Protein Kinase Inhibitors; Pyridines; Pyrimidines; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction

2009
Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2.
    The Journal of biological chemistry, 2013, May-31, Volume: 288, Issue:22

    Topics: Adaptor Proteins, Signal Transducing; Amides; Anilides; Benzamides; Cell Differentiation; Cells, Cultured; Colchicine; DNA-Binding Proteins; Enzyme Inhibitors; Formins; Gene Expression Regulation; Humans; Microtubule-Associated Proteins; Microtubules; Myofibroblasts; Oncogene Proteins, Fusion; Paclitaxel; Protein Transport; Pyridines; Serum Response Factor; Smad Proteins; Stress Fibers; Trans-Activators; Transforming Growth Factor beta; Tubulin Modulators

2013